HMRI research finds drugs can help late-stage melanoma patients

Professor Nikola Bowden. Picture suppled by HMRI

HUNTER researchers have found two existing drugs can improve survival times for patients with late-stage melanoma.

The Hunter Medical Research Institute team, led by Professor Nikola Bowden and Dr Andre van der Westhuizen, have published their findings in American Association for Cancer Research journal Cancer Research Communications.